Johns Hopkins Bayview Medical Campus
University of Minnesota
My broad clinical and preclinical expertise is the application of behavioral pharmacology and behavioral analysis to a scientific investigation of mood-altering drugs. Areas of specialization include hallucinogens and novel “club drugs”, caffeine self-administration, withdrawal and addiction, sedative self-administration and sedative effects, cigarette smoking and nicotine self-administration, alcohol self-administration, and baboon drug self-administration and drug discrimination.
Juliano, L.M., & Griffiths, R.R. (2004). A critical review of caffeine withdrawal: Empirical validation of symptoms and signs, incidence, severity, and associated features. Psychopharmacology, 176, 1-29.
Griffiths, R.R., & Johnson, M.W. (2005). Relative abuse liability of hypnotic drugs: A conceptual framework and algorithm for differentiating among compounds. Journal of Clinical Psychiatry, 66 (suppl. 9), 31-41.
Griffiths, R.R., Richards, W.A., McCann, U., & Jesse, R. (2006). Psilocybin can occasion mystical experiences having substantial and sustained personal meaning and spiritual significance. Psychopharmacology, 187, 268-283.
Carter, L.P. & Griffiths, R.R. (2009). Principles of laboratory assessment of drug abuse liability and implications for clinical development. Drug and Alcohol Dependence, 105S, S14-S25
Griffiths, R.R., Johnson, M.W., Richards, W.A., Richards, B.D., McCann, U., & Jesse, R. (2011). Psilocybin occasioned mystical-type experiences: Immediate and persisting dose-related effects. Psychopharmacology, 218(4), 649-665.
MacLean, K.A., Johnson, M.W., Reissig, C.J., Prisinzano, T.E., & Griffiths, R.R. (2012, published online). Dose-related effects of salvinorin A in humans: Dissociative, hallucinogenic and memory effects. Psychopharmacology
Juliano, L.M., Evatt, D.P., Richards, B.D., & Griffiths, R.R. (in press). Characterization of individuals seeking treatment for caffeine dependence. Psychology of Addictive Behaviors. 2011